DIEBOLD NIXDORF, Inc: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Oct 28, 2021 and accepted by EDGAR at Oct 28, 2021, 16:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-01 to 2021-09-30 | $958.2m | us-gaap:Revenues |
| Revenue | 9 months2021-01-01 to 2021-09-30 | $2.85bn | us-gaap:Revenues |
| Cost of revenue | 3 months2021-07-01 to 2021-09-30 | $698.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2021-01-01 to 2021-09-30 | $2.06bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-07-01 to 2021-09-30 | $260.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-01-01 to 2021-09-30 | $785.2m | us-gaap:GrossProfit |
| Research and development | 3 months2021-07-01 to 2021-09-30 | $25.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-01-01 to 2021-09-30 | $95.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-07-01 to 2021-09-30 | $195.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-01-01 to 2021-09-30 | $603.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-07-01 to 2021-09-30 | $38.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | $87.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $51.3m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-01-01 to 2021-09-30 | $149.7m | us-gaap:InterestExpense |
| Income tax | 3 months2021-07-01 to 2021-09-30 | −$1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-01-01 to 2021-09-30 | −$11.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-01 to 2021-09-30 | −$2.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-09-30 | −$40.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-01 to 2021-09-30 | −$0.03 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2021-01-01 to 2021-09-30 | −$0.52 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | −$291.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 9 months2021-01-01 to 2021-09-30 | $7.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2021-09-30 | $1.92bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $3.59bn | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $1.56bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2021-09-30 | −$872.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000028823-21-000139. Last ingested by Listed: Oct 28, 2026, 07:18 ET. Listed shows no prices and gives no investment advice.